litlas
ログインアカウント作成

Malcolm J. Moore

1987–2025 年に発表

113
論文数
54,563
被引用数
90
h 指数
112
i10 指数

被引用数

Malcolm J. Moore の年別被引用数1987 年: 被引用 1 件1988 年: 被引用 5 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 5 件1992 年: 被引用 2 件1993 年: 被引用 3 件1994 年: 被引用 5 件1995 年: 被引用 13 件1996 年: 被引用 16 件1997 年: 被引用 30 件1998 年: 被引用 26 件1999 年: 被引用 73 件2000 年: 被引用 92 件2001 年: 被引用 92 件2002 年: 被引用 149 件2003 年: 被引用 132 件2004 年: 被引用 168 件2005 年: 被引用 214 件2006 年: 被引用 233 件2007 年: 被引用 261 件2008 年: 被引用 277 件2009 年: 被引用 374 件2010 年: 被引用 443 件2011 年: 被引用 391 件2012 年: 被引用 449 件2013 年: 被引用 436 件2014 年: 被引用 444 件2015 年: 被引用 503 件2016 年: 被引用 459 件2017 年: 被引用 457 件2018 年: 被引用 421 件2019 年: 被引用 1,449 件2020 年: 被引用 1,471 件2021 年: 被引用 1,296 件2022 年: 被引用 838 件2023 年: 被引用 611 件2024 年: 被引用 954 件2025 年: 被引用 386 件2026 年: 被引用 14 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,456 件、この内訳の 27.6%中国: 引用元論文 1,334 件、この内訳の 8.3%ドイツ: 引用元論文 991 件、この内訳の 6.2%イギリス: 引用元論文 956 件、この内訳の 5.9%イタリア: 引用元論文 917 件、この内訳の 5.7%日本: 引用元論文 808 件、この内訳の 5%カナダ: 引用元論文 803 件、この内訳の 5%フランス: 引用元論文 712 件、この内訳の 4.4%オランダ: 引用元論文 518 件、この内訳の 3.2%スペイン: 引用元論文 507 件、この内訳の 3.1%オーストラリア: 引用元論文 416 件、この内訳の 2.6%韓国: 引用元論文 333 件、この内訳の 2.1%
0%27.6%その他 20.9%

機関

分野

  • Medicine73.8%
  • Biochemistry, Genetics and Molecular Biology18%
  • Immunology and Microbiology2%
  • Materials Science1.3%
  • Computer Science0.8%
  • Engineering0.7%
  • その他3.4%

トピック

  • Pancreatic and Hepatic Oncology Research11.1%
  • Colorectal Cancer Treatments and Studies5%
  • Cancer Genomics and Diagnostics3.9%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.8%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Cancer Cells and Metastasis1.9%
  • その他73.1%

共著者

全論文

検索で開く
  1. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    著者: Daniel D. Von Hoff, Thomas J. Ervin, Francis P. Arena, E. Gabriela Chiorean, Jeffrey R. Infante, Malcolm J. Moore, Thomas E. Seay, Sergei Tjulandin, Wen Wee, Mansoor N. Saleh, Marion Harris, Michele Reni, Scot Dowden, Daniel A. Laheru, Nathan Bahary, Ramesh K. Ramanathan, Josep Tabernero, Manuel Hidalgo, David Goldstein, Eric Van Cutsem, Xinyu Wei, José Iglesias, Markus F. Renschler - New England Journal of Medicine 2013 被引用: 6,661

  2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

    著者: Howard A. Burris, Malcolm J. Moore, John Sahl Andersen, M R Green, Mace L. Rothenberg, Manuel Modiano, M. Christine Cripps, Russell K. Portenoy, Anna Maria Storniolo, Peter G. Tarassoff, Ryan Nelson, F. Andrew Dorr, Connie Stephens, Daniel D. Von Hoff - Journal of Clinical Oncology 1997 被引用: 5,884

  3. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

    著者: Malcolm J. Moore, David Goldstein, John Hamm, Arié Figer, J. Randolph Hecht, Steven Gallinger, H. Au, P. Murawa, David Walde, Robert A. Wolff, Daniel de Castro, Robert Lim, Keyue Ding, Gary M. Clark, Theodora Voskoglou-Nomikos, Mieke Ptasynski, Wendy R. Parulekar - Journal of Clinical Oncology 2007 被引用: 3,859

  4. Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial

    著者: Kyaw Aung, Sandra E. Fischer, Robert E. Denroche, Gun-Ho Jang, Anna Dodd, Sean Creighton, Bernadette Southwood, Sheng‐Ben Liang, Dianne Chadwick, Amy Zhang, Grainne M. O’Kane, Hamzeh Albaba, Shari Moura, Robert C. Grant, Jessica K. Miller, Faridah Mbabaali, Danielle Pasternack, Ilinca M. Lungu, John M.S. Bartlett, Sangeet Ghai, Mathieu Lemire, Spring Holter, Ashton A. Connor, Richard A. Moffitt, Jen Jen Yeh, Lee E. Timms, Paul M. Krzyzanowski, Neesha C. Dhani, David W. Hedley, Faiyaz Notta, Julie M. Wilson, Malcolm J. Moore, Steven Gallinger, Jennifer J. Knox - Clinical Cancer Research 2017 被引用: 636

  5. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial

    著者: Camilla Zimmermann, Nadia Swami, Monika K. Krzyzanowska, Breffni Hannon, Natasha B. Leighl, Amit M. Oza, Malcolm J. Moore, Anne Rydall, Gary Rodin, Ian F. Tannock, Allan Donner, Christopher Lo - The Lancet 2014 被引用: 1,796

  6. K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer

    著者: Christos S. Karapetis, Shirin Khambata‐Ford, Derek J. Jonker, Chris J. O’Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. J. Simes, Haji Chalchal, Jeremy Shapiro, Sonia Robitaille, Timothy Price, Lois E. Shepherd, Heather‐Jane Au, Christiane Langer, Malcolm J. Moore, John Zalcberg - New England Journal of Medicine 2008 被引用: 3,597

  7. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

    著者: Hans von der Maase, Steen Werner Hansen, J.T. Roberts, Luigi Dogliotti, T. Oliver, Malcolm J. Moore, I. Bodrogi, Peter Albers, Alexander Knuth, Christian Lippert, Pierre Kerbrat, Pedro Sánchez‐Rovira, Peter Wersäll, Simon Cleall, D. Roychowdhury, Irene Tomlin, Carla Visseren‐Grul, PierFranco Conte - Journal of Clinical Oncology 2000 被引用: 2,286

  8. Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

    著者: John P. Neoptolemos, Deborah Stocken, Claudio Bassi, Paula Ghaneh, David Cunningham, David Goldstein, Robert Padbury, Malcolm J. Moore, Steven Gallinger, C. Mariette, Moritz N. Wente, Jakob R. Izbicki, Helmut Friess, Markus M. Lerch, Christos Dervenis, Attila Oláh, Giovanni Butturini, Ryuichiro Doi, Pehr Lind, David B. Smith, Juan W. Valle, Daniel H. Palmer, John Buckels, Joyce Thompson, Colin J. McKay, Charlotte Rawcliffe, Markus W. Büchler, for the European Study Group for Pancreatic Cancer - JAMA 2010 被引用: 1,387

  9. Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

    著者: Margaret A. Tempero, Uwe Pelzer, Eileen M. O’Reilly, Jordan M. Winter, Do‐Youn Oh, Chung‐Pin Li, Giampaolo Tortora, Heung-Moon Chang, Charles D. Lopez, Tanios Bekaii‐Saab, Andrew H. Ko, Armando Santoro, Joon Oh Park, Marcus Smith Noel, Giovanni Luca Frassineti, Yan‐Shen Shan, Andrew Dean, Hanno Riess, Eric Van Cutsem, Jordan Berlin, Philip Philip, Malcolm J. Moore, David Goldstein, Josep Tabernero, Mingyu Li, Stefano Ferrara, Yvan Le Bruchec, George Zhang, Brian Lu, Andrew V. Biankin, Michele Reni, Richard A. Epstein, Paul L. Vasey, Jeremy Shapiro, Matthew Burge, Yu Jo Chua, Marion Harris, Nick Pavlakis, Niall C. Tebbutt, Gerald W. Prager, Christian Dittrich, Friedrich Längle, Kathrin Philipp‐Abbrederis, Richard Greil, Herbert Stöger, Michael Girschikofsky, Thomas Kuehr, Jean–Luc Van Laethem, Stéphanie Laurent, Neesha C. Dhani, Yoo Joung Ko, Scot Dowden, Petr Kavan, Mustapha Édouard Tehfe, Eugen Kubala, Milan Kohoutek, Per Pfeiffer, Mette Yilmaz, Vibeke K. Parner, Tapio Salminen, Leena‐Maija Soveri, Eija Korkeila, Pia Österlund, Julien Taı̈eb, David Tougeron, Pascal Artru, François‐Xavier Caroli‐Bosc, Rosine Guimbaud, Antony Turpin, Thomas Walter, Jean‐Baptiste Bachet, Volker Kunzmann, Florian Kreth, Andreas De Block, Marino Venerito, Helmut Oettle, Meinolf Karthaus, Jörg Trojan, Gunnar Folprecht, Markus M. Lerch, Frank Kullmann, Marcel Reiser, Volker Heinemann, Marcus‐Alexander Wörns, H. Schulz, Benjamin Garlipp, Thomas Yau, Lam Stephen Chan, Balázs Juhász, László Landherr, Tamás Pintér, G. Bodoky, Zsuzsanna Kahán, Raymond McDermott, Derek G. Power, Luca Gianni, Salvatore Siena, Michèle Milella, Alfredo Falcone, Rossana Berardi ほか 87 名 - Journal of Clinical Oncology 2022 被引用: 132

  10. Cetuximab for the Treatment of Colorectal Cancer

    著者: Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis, John Zalcberg, Dongsheng Tu, Heather-Jane Au, Scott Berry, Marianne Krahn, Timothy Price, R. J. Simes, Niall C. Tebbutt, Guy van Hazel, Rafal Wierzbicki, Christiane Langer, Malcolm J. Moore - New England Journal of Medicine 2007 被引用: 1,806

  11. Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

    著者: Arjun Gupta, Christopher J. O’Callaghan, Liting Zhu, Derek J. Jonker, Ralph Wong, Bruce Colwell, Malcolm J. Moore, Christos S. Karapetis, Niall C. Tebbutt, Jeremy Shapiro, Dongsheng Tu, Christopher M. Booth - JCO Oncology Practice 2023 被引用: 69

  12. Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer

    著者: Joanna M. Karasinska, James T. Topham, Steve E. Kalloger, Gun Ho Jang, Robert E. Denroche, Luka Culibrk, Laura M. Williamson, Hui‐Li Wong, Michael K.C. Lee, Grainne M. O’Kane, Richard A. Moore, Andrew J. Mungall, Malcolm J. Moore, Cassia Warren, Andrew Metcalfe, Faiyaz Notta, Jennifer J. Knox, Steven Gallinger, Janessa Laskin, Marco A. Marra, Steven J.M. Jones, Daniel J. Renouf, David F. Schaeffer - Clinical Cancer Research 2019 被引用: 232

  13. Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer

    著者: Leonard B. Saltz, John V. Cox, Charles D. Blanke, Lee S. Rosen, Louis Fehrenbacher, Malcolm J. Moore, Jean A. Maroun, Stephen P. Ackland, Paula K. Locker, Nicoletta Pirotta, Gary Elfring, Langdon L. Miller - New England Journal of Medicine 2000 被引用: 3,010

  14. Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

    著者: John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox, Juan W. Valle, Daniel H. Palmer, Alexander C. McDonald, Ross Carter, Niall C. Tebbutt, Christos Dervenis, David Smith, Bengt Glimelius, Richard Charnley, F Lacaine, Andrew Scarfe, Mark R. Middleton, Alan Anthoney, Paula Ghaneh, Christopher Halloran, Markus M. Lerch, Attila Oláh, Charlotte Rawcliffe, Caroline S. Verbeke, Fiona Campbell, Markus W. Büchler, for the European Study Group for Pancreatic Cancer - JAMA 2012 被引用: 592

  15. Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

    著者: Talia Golan, Zaheer Kanji, Ron Epelbaum, Nicholas Devaud, Efrat Dagan, Spring Holter, Dan Aderka, Shani Paluch–Shimon, Brett A. Kaufman, Ruth Gershoni‐Baruch, David W. Hedley, Malcolm J. Moore, Eitan Friedman, Steven Gallinger - British Journal of Cancer 2014 被引用: 438

  16. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

    著者: Aimery de Gramont, Eric Van Cutsem, Hans‐Joachim Schmoll, Josep Tabernero, Stephen Clarke, Malcolm J. Moore, David Cunningham, Thomas H. Cartwright, J. Randolph Hecht, Fernando Rivera, Seock‐Ah Im, G. Bodoky, Ramón Salazar, Frédérique Maindrault-Goebel, Einat Shacham‐Shmueli, Emilio Bajetta, Martina Makrutzki, Aijing Shang, Thierry André, Paulo M. Hoff - The Lancet Oncology 2012 被引用: 526

  17. NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma

    著者: Martin Jones, Laura Williamson, James T. Topham, Michael K.C. Lee, Angela Goytain, Julie Ho, Robert E. Denroche, Gun-Ho Jang, Erin Pleasance, Yaoquing Shen, Joanna M. Karasinska, John Paul McGhie, Sharlene Gill, Howard J. Lim, Malcolm J. Moore, Hui‐Li Wong, Tony Ng, Stephen Yip, Wei Zhang, Sara Sadeghi, Carolyn Reisle, Andrew J. Mungall, Karen Mungall, Richard A. Moore, Yussanne Ma, Jennifer J. Knox, Steven Gallinger, Janessa Laskin, Marco A. Marra, David F. Schaeffer, Steven J.M. Jones, Daniel J. Renouf - Clinical Cancer Research 2019 被引用: 159

  18. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial

    著者: Charles S. Fuchs, Sérgio Jobim Azevedo, Takuji Okusaka, Jean‐Luc Van Laethem, Lara Lipton, Hanno Riess, Cezary Szczylik, Malcolm J. Moore, Marc Peeters, G. Bodoky, Masafumi Ikeda, Bohuslav Melichar, Radim Němeček, S. Ohkawa, Anna Świeboda-Sadlej, Sergei Tjulandin, Eric Van Cutsem, Robert D. Loberg, Vincent Haddad, Jennifer Gansert, Bruce Allen Bach, Alfredo Carrato - Annals of Oncology 2015 被引用: 164

  19. Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

    著者: Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore - Journal of Clinical Oncology 2009 被引用: 643

  20. PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy

    著者: Sharlene Gill, Yoo‐Joung Ko, C. Cripps, Annie Beaudoin, Sukhbinder Dhesy‐Thind, Muhammad Zulfiqar, Paweł Zalewski, Thuan Do, Pablo Cano, Wendy Yin Han Lam, Scot Dowden, Helene Grassin, John A. Stewart, Malcolm J. Moore - Journal of Clinical Oncology 2016 被引用: 291

  21. DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy

    著者: Frank A. Sinicrope, Nathan R. Foster, Stephen N. Thibodeau, Silvia Marsoni, G Monges, Roberto Labianca, Greg Yothers, Carmen J. Allegra, Malcolm J. Moore, Steven Gallinger, Daniel J. Sargent - JNCI Journal of the National Cancer Institute 2011 被引用: 529

  22. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma

    著者: Spring Holter, Ayelet Borgida, Anna Dodd, Robert C. Grant, Kara Semotiuk, David W. Hedley, Neesha C. Dhani, Steven A. Narod, Mohammad R. Akbari, Malcolm J. Moore, Steven Gallinger - Journal of Clinical Oncology 2015 被引用: 396

  23. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

    著者: Stephanie Yasmin Brule, Derek J. Jonker, Christos S. Karapetis, Chris J. O’Callaghan, Malcolm J. Moore, Ralph Wong, Niall C. Tebbutt, Craig Underhill, Desmond Yip, John Zalcberg, Dongsheng Tu, Rachel Goodwin - European Journal of Cancer 2015 被引用: 337

  24. Advanced pancreatic carcinoma: current treatment and future challenges

    著者: Anastasios Stathis, Malcolm J. Moore - Nature Reviews Clinical Oncology 2010 被引用: 791